ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

More Workers Quit Smoking When Health Messages Combined

August 30, 2002

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

Sharon Murphy To Head New Research Center in San Antonio

August 2, 2002